Treatment of autoimmune diabetes in NOD mice by Toll-like receptor 2 tolerance in conjunction with dipeptidyl peptidase 4 inhibition
According to the Summary of Product Characteristics (SmPC) approved by the Medicines and Healthcare products Regulatory Agency (MHRA), serious but less common adverse effects can include pancreatitis, gallbladder disease, hypoglycaemia (particularly when used with insulin or sulfonylureas), and allergic reactions
Research is investigating whether it can support heart function, particularly in certain metabolic or heart conditions
Although I took Wegovy for my weight loss, the same problems I describe here exist for all of the new drugs in this category (Wegovy, Saxenda, Mounjaro, semaglutide, liraglutide, tirzepatide, and others) because they are all very similar drugs that work in very similar ways
It's not a single, straightforward path